The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
SPN-830 provides a continuous subcutaneous infusion of apomorphine, a non-ergoline dopamine agonist, through an infusion pump. Otsuka and Lundbeck are seeking another indication for brexpiprazole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback